Teresa Graham, Roche Pharmaceuticals CEO
Roche's portfolio 'rejuvenation' fuels 9% increase in drug sales, led by eye treatment
Roche reported a 9% increase in pharma sales during the first quarter, with executives chalking up the bump to “rejuvenation” in its pharmaceutical portfolio that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.